Medicare/Medicaid reimbursement rate changes for ambulatory infusion services and DME codes
Oncology treatment volumes and chemotherapy utilization trends (drives pump rental demand)
Payor contract wins or losses with major health systems and oncology networks
Pump utilization rates and average rental duration per patient episode
low-to-moderate - Healthcare services exhibit defensive characteristics as cancer treatment and post-surgical care are non-discretionary. However, elective procedure volumes (which drive some pump demand) can decline during recessions. Commercial insurance enrollment affects payor mix, with economic downturns shifting patients toward government programs. Overall revenue is more tied to demographic trends (aging population, cancer incidence) than GDP growth, but margin pressure can emerge from cost-cutting by hospitals during economic stress.
Rising rates modestly pressure valuation multiples for low-growth healthcare services stocks, as investors rotate toward higher-yielding alternatives. The company's 0.45x debt/equity suggests manageable interest expense sensitivity. Higher rates could constrain acquisition financing for industry consolidation, potentially reducing competitive M&A activity. Conversely, rate increases have minimal direct impact on operating performance since rental contracts are not rate-indexed and customer demand is clinically driven rather than financing-dependent.
Medicare reimbursement cuts or policy changes to DME rental categories could compress margins or eliminate product lines, as CMS periodically reviews competitive bidding programs and payment rates
Technological shift toward integrated hospital infusion systems or disposable pump technologies could reduce demand for traditional ambulatory rental pumps, particularly if hospitals vertically integrate infusion services
Regulatory compliance burden increases (FDA device reporting, HIPAA, state licensing) disproportionately impact small-cap DME providers versus larger diversified competitors with scale advantages
value - The stock trades at 1.1x P/S and 7.3x EV/EBITDA, below broader healthcare equipment averages, attracting value investors seeking turnaround potential or asset-based plays. Recent 175% EPS growth (off low base) and negative 12-month return create contrarian opportunity for investors betting on operational improvement. Low institutional ownership typical of micro-cap healthcare services. Not suitable for growth investors given 7.2% revenue growth and mature DME market dynamics. Minimal dividend yield eliminates income investor appeal.
Trend
-8.8% vs SMA 50 · -5.6% vs SMA 200
Momentum
Heavy distribution on elevated volume — institutions appear to be exiting. Squeeze setups unlikely while selling pressure persists.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
ANALYST ESTIMATES
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2023 | $129.4M $128.4M–$130.8M | — | $0.02 | — | ±1% | Low1 |
FY2024 | $135.9M $134.9M–$137.5M | ▲ +5.1% | $0.14 | ▲ +725.6% | ±1% | Low2 |
FY2025 | $143.9M $143.8M–$144.0M | ▲ +5.8% | $0.29 | ▲ +103.5% | ±2% | Moderate3 |
INSTITUTIONAL OWNERSHIP
INFU News
About
InfuSystem Holdings, Inc., is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is Integrated Therapy Services ('ITS'), providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The ITS segment is comprised of Oncology, Pain Management, and Wound Therapy businesses. The second platform, Durable Medical Equipment Services ('DME Services'), supports the ITS platform and leverages strong service orientation to win incremental business from its direct payor clients. The DME Services segment is comprised of direct payor rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts and Ontario, Canada.
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
INFU◀ | $8.77 | +0.00% | $177M | 22.4 | +635.8% | 462.0% | 1500 |
| $404.35 | -3.20% | $2.1T | 30.5 | +3296.8% | 4510.0% | 1500 | |
| $132.58 | -6.05% | $307.9B | 20.7 | -44.8% | 1012.0% | 1500 | |
| $88.38 | -2.58% | $303.7B | 13.6 | +318.8% | 1510.7% | 1500 | |
| $148.08 | -1.13% | $282.6B | 21.0 | +597.3% | 2564.4% | 1500 | |
| $181.58 | -1.83% | $281.6B | 26.9 | +862.9% | 1745.9% | 1500 | |
| $183.40 | -0.23% | $256.1B | 16.8 | +213.3% | 1482.4% | 1500 | |
| Sector avg | — | -2.15% | — | 21.7 | +840.0% | 1898.2% | 1500 |